癌症潜伏期是否已过时?来自慢性髓性白血病的启示
本文以慢性髓性白血病为模型,讨论传统癌症潜伏期定义(从暴露于致癌物到诊断的间隔)不能准确反映当前对多数癌症如何发生的认识,因为其假设单次暴露是唯一病因、忽略癌症随机诊断时间及加速效应。作者指出难以确定潜伏期计时起点与终点,即使基因相同、驱动突变相同的双胞胎发病间隔也差异显著,并提出需要新定义或放弃该概念。
要点
- 传统癌症潜伏期定义(暴露至诊断)不能准确反映多数癌症发生规律
- 以慢性髓性白血病为模型,难以确定潜伏期计时的起点事件或突变
- 即使基因相同、驱动突变相同的双胞胎,发病间隔也差异显著
核心结论
- 需要新的癌症潜伏期定义,或在现代癌症生物学时代放弃癌症潜伏期概念。
研究设计与样本
- 本文为以慢性髓性白血病为模型的论述性文章,讨论癌症潜伏期定义问题。
主要发现
- 传统定义假设单次暴露是癌症唯一病因,忽略癌症可能原本就会发生而暴露仅加速其发展,并忽略诊断时间的随机性。
- 难以或不可能确定从哪个事件或突变开始计时以测量癌症潜伏期。
- 鉴于癌症诊断时间的随机性,同样难以确定何时停止计时。
- 即使基因相同、驱动突变相同的双胞胎,发生癌症的间隔也差异显著。
- 文中还讨论了其他混杂因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Our concept of cancer latency, the interval from when a cancer starts until it is diagnosed, has changed dramatically. A prior widely-used definition was the interval between an exposure to a cancer-causing substance and cancer diagnosis. However, this definition does not accurately reflect current knowledge of how most cancers develop assuming, mostly incorrectly, one exposure is the sole cause of a cancer, ignoring the possibility the cancer being considered would have developed anyway but that the exposure accelerated cancer development and eliding the randomness in when a cancer is diagnosed. We show, using chronic myeloid leukaemia as a model, that defining cancer latency is not as simple as it once seemed. It is difficult or impossible to know at which event or mutation to start to clock to measure cancer latency. It is equally difficult to know when to stop the clock given the stochastic nature of when cancers are diagnosed. Importantly, even in genetically-identical twins with the same driver mutation intervals to develop cancer vary substantially. And we discuss other confonders. Clearly we need a new definition of cancer latency or we need to abandon the concept of cancer latency in the modern era of cancer biology.
引用
- Abecasis M, Cross NCP, Brito M, et al. Is cancer latency an outdated concept? Lessons from chronic myeloid leukemia. Leukemia. 2020. PMID: 32632094. doi:10.1038/s41375-020-0957-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。